Understanding how a specific enzyme affects healing after burn injuries
5-Lipoxygenase exerts dual and opposing functions during the wound healing process
This study is looking at how a specific enzyme called 5-Lipoxygenase affects the healing of burn injuries, with the goal of finding better ways to help patients heal faster and more effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10667543 on NIH RePORTER |
What this research studies
This research investigates the role of the 5-Lipoxygenase (5-LO) enzyme in the healing process of burn injuries. It aims to understand how this enzyme influences the production of leukotrienes, which are lipid mediators involved in inflammation and tissue repair. By examining the activity of 5-LO at burn sites, the research seeks to identify mechanisms that could lead to improved healing outcomes for patients with burn injuries. The study will also explore how different leukotrienes may have opposing effects on the healing process, potentially guiding new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have sustained burn injuries and are experiencing impaired healing.
Not a fit: Patients with minor burns that heal without complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches that enhance healing for patients with burn injuries.
How similar studies have performed: Previous research has shown that targeting inflammatory pathways can improve healing, suggesting that this approach may also yield positive results.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Soulika, Athena — University of California at Davis
- Study coordinator: Soulika, Athena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.